Literature DB >> 29230700

Disclosure is Inadequate as a Solution to Managing Conflicts of Interest in Human Research.

Helene Jacmon1.   

Abstract

Disclosure is a common response to conflicts of interest; it is intended to expose the conflict to scrutiny and enable it to be appropriately managed. For disclosure to be effective the receiver of the disclosure needs to be able to use the information to assess how the conflict may impact on their interests and then implement a suitable response. The act of disclosure also creates an expectation of self-regulation, as the person with the conflicting interests will be mindful of their own potential biases and aware that their decisions may be monitored. This article discusses some of the problems of relying on disclosure as a solution to address conflicts of interest in research, including the added complexities around institutional conflicts of interest. The case of Dan Markingson illustrates these issues and highlights the vulnerable position relying on disclosure as a solution leaves research participants in.

Entities:  

Keywords:  Conflicts of Interest; Dan Markingson; Disclosure; Research ethics

Mesh:

Year:  2017        PMID: 29230700     DOI: 10.1007/s11673-017-9824-7

Source DB:  PubMed          Journal:  J Bioeth Inq        ISSN: 1176-7529            Impact factor:   1.352


  15 in total

1.  Dancing with the porcupine: rules for governing the university-industry relationship.

Authors:  S Lewis; P Baird; R G Evans; W A Ghali; C J Wright; E Gibson; F Baylis
Journal:  CMAJ       Date:  2001-09-18       Impact factor: 8.262

2.  A social science perspective on gifts to physicians from industry.

Authors:  Jason Dana; George Loewenstein
Journal:  JAMA       Date:  2003-07-09       Impact factor: 56.272

3.  Financial conflicts of interest in human subjects research: the problem of institutional conflicts.

Authors:  Mark Barnes; Patrik S Florencio
Journal:  J Law Med Ethics       Date:  2002       Impact factor: 1.718

4.  Secret ethics business?

Authors:  Lynn Gillam
Journal:  Monash Bioeth Rev       Date:  2003-01

5.  Biomedical conflicts of interest: a defence of the sequestration thesis-learning from the cases of Nancy Olivieri and David Healy.

Authors:  A Schafer
Journal:  J Med Ethics       Date:  2004-02       Impact factor: 2.903

6.  The effects of pharmaceutical firm enticements on physician prescribing patterns. There's no such thing as a free lunch.

Authors:  J P Orlowski; L Wateska
Journal:  Chest       Date:  1992-07       Impact factor: 9.410

7.  Disclosing conflicts of interest to research subjects: an ethical and legal analysis.

Authors:  David B Resnik
Journal:  Account Res       Date:  2004 Apr-Jun       Impact factor: 2.622

8.  Institutional Pathology and the Death of Dan Markingson.

Authors:  Carl Elliott
Journal:  Account Res       Date:  2016-10-18       Impact factor: 2.622

9.  The burden of disclosure: increased compliance with distrusted advice.

Authors:  Sunita Sah; George Loewenstein; Daylian M Cain
Journal:  J Pers Soc Psychol       Date:  2012-10-22

10.  Understanding financial conflicts of interest.

Authors:  D F Thompson
Journal:  N Engl J Med       Date:  1993-08-19       Impact factor: 91.245

View more
  3 in total

Review 1.  Conflicts of interest in infection prevention and control research: no smoke without fire. A narrative review.

Authors:  Mohamed Abbas; Daniela Pires; Alexandra Peters; Chantal M Morel; Samia Hurst; Alison Holmes; Hiroki Saito; Benedetta Allegranzi; Jean-Christophe Lucet; Walter Zingg; Stephan Harbarth; Didier Pittet
Journal:  Intensive Care Med       Date:  2018-09-11       Impact factor: 17.440

2.  The Power of Knowledge, Responses to Change, and the Gymnastics of Causation.

Authors:  Michael A Ashby; Bronwen Morrell
Journal:  J Bioeth Inq       Date:  2018-03       Impact factor: 1.352

Review 3.  Are Corporations Re-Defining Illness and Health? The Diabetes Epidemic, Goal Numbers, and Blockbuster Drugs.

Authors:  Linda M Hunt; Elisabeth A Arndt; Hannah S Bell; Heather A Howard
Journal:  J Bioeth Inq       Date:  2021-09-06       Impact factor: 2.216

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.